Select Page

“With this acquisition, IBM will be one of the world’s leading health data, analytics and insights companies, and the only one that can deliver the unique cognitive capabilities of the Watson platform,” said Deborah DiSanzo, general manager for IBM Watson Health. “Truven’s impressive team, extensive client roster, and expansive data sets complement Watson Health’s broad-based team, capabilities and offerings. Together, we’re well positioned to scale globally and to build first-in-class offerings designed to help our clients apply cognitive insights in a value-based care environment.” “The Truven Health Analytics team is eager to combine our capabilities and expertise with the Watson Health portfolio,” said Mike Boswood, president and CEO, Truven Health Analytics. “This will help catapult the industry forward to transform healthcare and to save and improve lives.” The deal is expected to close later this year, subject to satisfaction of customary closing conditions and applicable regulatory reviews. Watson Health Offerings Optimized for Value-Based Care Value-based care is an emerging healthcare model that aims to improve the quality of care while controlling costs and driving better near- and long-term health outcomes for individuals. While traditional health systems have paid for volume based on a fee-for-service model, value-based care models use payment incentives that aim to advance quality outcomes at lower cost. This payment model requires that providers, payers and other stakeholders have evidence — data and insight — to document how specific elements of care contribute to achieving a target health outcome for a given cost. Watson Health offerings will be optimized to help clients succeed in this environment by helping them achieve better patient outcomes at reduced cost through advanced analytics and actionable insights. Truven Health Analytics owns some of the most trusted brands in healthcare, such as MarketScan, 100 Top Hospitals, Advantage Suite, Micromedex, Simpler, ActionOI and JWA. Truven Health Analytics is headquartered in Ann Arbor, Michigan, with offices in Denver, Chicago, Raleigh-Durham, and a center in India. Watson is the first commercially available cognitive computing capability representing a new era in computing. The system, delivered through the cloud, analyzes high volumes of data, understands complex questions posed in natural language, and proposes evidence-based answers. Watson continuously learns, gaining in value and knowledge over time, from previous interactions. In April 2015, the company launched IBM Watson Health and the Watson Health Cloud platform. The new unit will help improve the ability of doctors, researchers and insurers to innovate by surfacing insights from the massive amount of personal health data being created and shared daily. The Watson Health Cloud allows this information to be de-identified, shared and combined with a dynamic and constantly growing aggregated view of clinical, research and social health data. Veritas Capital is a private equity firm that invests in companies that provide critical products and services to government and commercial customers worldwide. It specializes in leveraged recapitalizations, buyouts, and growth capital investments in middle market companies. Veritas has made 70 investments and acquisitions in aerospace and defense, communications, education, energy, government services, healthcare, national security, and technology industries. Veritas has assembled a premier team of senior investment professionals led by managing partners Ramzi M. Musallam and Hugh D. Evans. The firm was founded in 1992 and is based in New York, N.Y., with an additional office in Washington, DC.]]>